DK134288A - Kemo-radio-immuno-konjugat og fremgangsmaade til fremstilling heraf - Google Patents

Kemo-radio-immuno-konjugat og fremgangsmaade til fremstilling heraf

Info

Publication number
DK134288A
DK134288A DK134288A DK134288A DK134288A DK 134288 A DK134288 A DK 134288A DK 134288 A DK134288 A DK 134288A DK 134288 A DK134288 A DK 134288A DK 134288 A DK134288 A DK 134288A
Authority
DK
Denmark
Prior art keywords
chemo
radio
preparing
procedure
immuno conjugate
Prior art date
Application number
DK134288A
Other languages
Danish (da)
English (en)
Other versions
DK134288D0 (da
Inventor
Joseph A Sinkule
Donald J Buchsbaum
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of DK134288D0 publication Critical patent/DK134288D0/da
Publication of DK134288A publication Critical patent/DK134288A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A61K51/1096—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK134288A 1987-03-11 1988-03-11 Kemo-radio-immuno-konjugat og fremgangsmaade til fremstilling heraf DK134288A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3070087A 1987-03-11 1987-03-11

Publications (2)

Publication Number Publication Date
DK134288D0 DK134288D0 (da) 1988-03-11
DK134288A true DK134288A (da) 1988-09-12

Family

ID=21855550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK134288A DK134288A (da) 1987-03-11 1988-03-11 Kemo-radio-immuno-konjugat og fremgangsmaade til fremstilling heraf

Country Status (6)

Country Link
EP (1) EP0282057A3 (fr)
JP (1) JPS63301833A (fr)
CN (1) CN88102026A (fr)
AU (1) AU1301788A (fr)
DK (1) DK134288A (fr)
NO (1) NO881077L (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0337598A3 (fr) * 1988-02-26 1991-07-03 Georgia State University Foundation, Inc. Utilisation de porphyrines et de métalloporphyrines dans le traitement de maladies causées par HIV
US5094950A (en) * 1988-06-07 1992-03-10 Nihon Medi-Physics Co., Ltd. Diethylenetriamine pentaacetic acid derivatives
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
IE63847B1 (en) * 1989-05-05 1995-06-14 Res Dev Foundation A novel antibody delivery system for biological response modifiers
AU629367B2 (en) * 1989-06-19 1992-10-01 Akzo N.V. Radioimmunotherapy using alpha-particles emission
US5030450A (en) * 1989-11-28 1991-07-09 Abbott Laboratories Method for inhibiting nematode infection of plants with Nematostatic trichothecene compositions
WO1991013633A1 (fr) * 1990-03-12 1991-09-19 Cancer Research Campaign Technology Limited Ameliorations concernant l'immunoradiotherapie
DE19514088A1 (de) * 1995-04-13 1996-10-17 Deutsches Krebsforsch Konjugat zur Behandlung von Entzünduns-, Infektions- und/oder Hauterkrankungen
EP0855910A4 (fr) * 1995-10-18 2000-07-05 Merck & Co Inc Conjugues utiles pour traiter l'adenome prostatique benin
WO1998009651A1 (fr) * 1996-09-03 1998-03-12 Chugai Seiyaku Kabushiki Kaisha COMPLEXES D'ANTICORPS ANTI-INTEGRINE α3
JP5064608B2 (ja) * 1998-05-26 2012-10-31 スローン−ケッタリング インスティトゥート フォー カンサー リサーチ アルファ粒子放出構成物およびその使用方法
US7736651B1 (en) 2000-11-24 2010-06-15 Sloan-Kettering Institute For Cancer Research Alpha emitting constructs and uses thereof
CN1110322C (zh) * 1999-07-21 2003-06-04 中国医学科学院医药生物技术研究所 单克隆抗体Fab'－平阳霉素偶联物及其抗肿瘤作用
NO314537B1 (no) * 1999-12-06 2003-04-07 Anticancer Therapeutic Inv Sa Reseptorbindende konjugater
ZA200305980B (en) 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
WO2003007889A2 (fr) 2001-07-17 2003-01-30 Research Development Foundation Agents therapeutiques contenant des proteines pro-apoptotiques
DE102004016355A1 (de) * 2004-04-02 2005-11-03 Rösner Research GmbH & Co.KG Herstellung und Verwendung des Konjugats Methotrexat-Albumin als Mittel zur Immunosuppression bei GVHD
DE102004057196A1 (de) * 2004-11-26 2006-06-01 Rösner Research GmbH & Co.KG Verfahren zur Herstellung von Albumin-Konjugaten mit Nicht-steroidalen Antirheumatika (NSAR)
WO2008043148A1 (fr) * 2006-10-11 2008-04-17 Medvet Science Pty. Ltd. Utilisation d'un agent endommageant l'adn et d'un ligand pour le traitement de cancer
CN108226531A (zh) * 2017-12-27 2018-06-29 三诺生物传感股份有限公司 一种β2-微球蛋白检测试剂盒
AU2021390552A1 (en) * 2020-12-04 2023-06-29 The Regents Of The University Of California Peptide receptor radionuclide therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001720A1 (fr) * 1984-09-13 1986-03-27 Cytogen Corporation Conjugues d'agents therapeutiques-anticorps

Also Published As

Publication number Publication date
CN88102026A (zh) 1988-09-28
JPS63301833A (ja) 1988-12-08
EP0282057A3 (fr) 1990-03-07
EP0282057A2 (fr) 1988-09-14
AU1301788A (en) 1988-09-15
DK134288D0 (da) 1988-03-11
NO881077D0 (no) 1988-03-10
NO881077L (no) 1988-09-12

Similar Documents

Publication Publication Date Title
DK265188A (da) Benzopyraner og pyranopyridiner og fremgangsmaade til fremstilling deraf
DK134288D0 (da) Kemo-radio-immuno-konjugat og fremgangsmaade til fremstilling heraf
DK665187A (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf
DK260687D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
NO880614D0 (no) Fremgangsmaate og anordning for tilberedning av kaffe.
DK96394A (da) 5-Halogenalkylidinimono-1-arylpyrazoler og fremgangsmåde til fremstilling deraf
DK69989D0 (da) Benzodioxolderivater og fremgangsmaade til fremstilling deraf
NO901745D0 (no) Fremgangsmaate og system for aa gjennomfoere minesveiping.
DK1693A (da) Pyranobenzoxadiazolderivat og fremgangsmaade til fremstilling deraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK225788D0 (da) Poroes harpiksfilm og fremmgangsmaade til fremstilling deraf
DK397788A (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
DK103889A (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK585988A (da) Isopolypeptider og fremgangsmaade til fremstilling deraf
DK487688A (da) Benzofuranderivater og fremgangsmaade til fremstilling deraf
DK25388D0 (da) Kondenserede pyrazolderivater og fremgangsmaade til fremstilling heraf
DK624588D0 (da) 4-demethoxy-anthracyclin-derivater og fremgangsmaade til fremstilling deraf
DK660387A (da) Maleimidgruppeholdige formstofblandinger og fremgangsmaade til fremstilling deraf
DK129689A (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
DK485988A (da) Bovint placentrat lactogen og fremgangsmaade til fremstilling deraf
DK319188A (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf
DK287787A (da) Isoxazolidinonderivater og fremgangsmaade til fremstilling deraf
DK335288D0 (da) Peptolidderivater og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment